Ubs Asset Management Americas Inc Axogen, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 41,510 shares of AXGN stock, worth $454,949. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,510Holding current value
$454,949% of portfolio
0.0%Shares
18 transactions
Others Institutions Holding AXGN
# of Institutions
191Shares Held
39.2MCall Options Held
61.7KPut Options Held
42.8K-
First Light Asset Management, LLC Edina, MN4.47MShares$49 Million10.62% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$35.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.6MShares$28.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$27.8 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.59MShares$17.4 Million0.54% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $463M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...